RareCyte is a biotechnology company that develops and manufactures rare cell detection and analysis platforms. The company's proprietary platform, the AccuCyte® Sample Preparation System, enables researchers to detect and analyze rare cells with high sensitivity and specificity. RareCyte's technology has applications in cancer research, liquid biopsy, prenatal testing, and infectious disease research. The company was founded in 2009 and is headquartered in Seattle, Washington.